当前位置: 首页 > 期刊 > 《中国当代医药》 > 2011年第21期
编号:12107991
盐酸坦索罗辛联合非那雄胺对延缓和预防BPH临床进展的疗效观察
http://www.100md.com 2011年7月25日 《中国当代医药》 2011年第21期
     [摘要] 目的:探讨坦索罗辛联合非那雄胺对延缓和预防良性前列腺增生临床进展性的疗效。方法:对具有前列腺增生临床进展高危因素的患者给予坦索罗辛联合非那雄胺治疗,观察治疗前后各项相关指标的变化,并进行统计学处理。结果:全部患者症状显著改善,临床进展的风险显著降低。结论:坦索罗辛联合非那雄胺能显著降低良性前列腺增生临床进展,显著减少急性尿潴留的发生和外科干预的风险。

    [关键词] 良性前列腺增生;临床进展性;坦索罗辛;非那雄胺

    [中图分类号] R697+.32 [文献标识码]B[文章编号]1674-4721(2011)07(c)-096-02

    Efficacy observation of tamsulosin combined finasteride on delay and prevention the progression of BPH

    TAO Zhongjie

    Department of Surgery, Taihe Central Hospital of Dongpo District, Meishan City, Sichuan Province, Meishan 620039, China

    [Abstract] Objective: To investigate the efficacy of tamsulosin and finasteride on delay and prevention the clinical progression of benign prostatic hyperplasia efficacy (BPH). Methods: Patients with clinical progress risk factors of benign prostatic hyperplasia were treated with tamsulosin and finasteride. Observed the changes of the relevant indicators before and after treatment, and were given statistical analysis. Results: All symptoms of patients significantly improved and significantly reduced the risk of clinical progression. Conclusion: Tamsulosin and finasteride can significantly reduce the incidence of the clinical progression of benign prostatic hyperplasia. ......
1 2下一页

您现在查看是摘要页,全文长 4939 字符